在异形间歇性肺炎亚型之间对急性恶化的预后比较:全国性的观察性研究
Nobuyasu Awano1, Shotaro Aso2, Takehiro Izumo1
1Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan.
Respiratory investigation
|October 7, 2025
概括
异形间歇性肺炎 (AE-IIPs) 的急性恶化是严重的. 患有异常性肺纤维化 (IPF),非特异性间歇性肺炎 (NSIP) 和急性间歇性肺炎 (AIP) 的患者的住院死亡率高于患有密码性组织性肺炎 (COP) 的患者.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 流行病学 流行病学
背景情况:
- 异形间歇性肺炎 (AE-IIPs) 的急性恶化是危及生命的,对亚型的预后数据比较有限.
- 了解AE-IIP亚型之间的住院死亡率差异对于临床管理至关重要.
研究的目的:
- 评估和比较主要AE-IIP亚型的住院死亡率.
- 在急性恶化期间识别具有显著不同预后的亚型.
主要方法:
- 对6645名IPF,NSIP,COP或AIPAE患者的回顾性分析,这些患者接受了高剂量甲基prednisolone治疗.
- 来自日本诊断程序组合数据库 (2010-2023) 的数据.
- 用于调整死亡率分析的多变量逻辑回归和概括估计方程.
主要成果:
- 在医院的死亡率:IPF 53.9%,NSIP 40.1%,COP 17.6%,AIP 49.3%. 在医院的死亡率:IPF 53.9%,NSIP 40.1%,COP 17.6%,AIP 49.3%.
- 调整后的分析显示,与COP相比,IPF (OR 3.92),NSIP (OR 2.80) 和AIP (OR 3.07) 的住院死亡率显著更高.
- 对于14日和28日死亡率观察到类似的趋势.
结论:
- 患有AE-IPF,AE-NSIP和AE-AIP的患者的住院死亡率明显高于患有AE-COP的患者.
- AE-IPF和AE-AIP与特别不良的预后有关.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.6K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K


